0000899243-22-023640.txt : 20220622
0000899243-22-023640.hdr.sgml : 20220622
20220622203921
ACCESSION NUMBER: 0000899243-22-023640
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220616
FILED AS OF DATE: 20220622
DATE AS OF CHANGE: 20220622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McMurry-Heath Michelle
CENTRAL INDEX KEY: 0001904156
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37844
FILM NUMBER: 221033383
MAIL ADDRESS:
STREET 1: C/O BIOVENTUS INC.
STREET 2: 4721 EMPEROR BOULEVARD, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bioventus Inc.
CENTRAL INDEX KEY: 0001665988
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 810980861
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4721 EMPEROR BOULEVARD, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: (919) 474-6700
MAIL ADDRESS:
STREET 1: 4721 EMPEROR BOULEVARD, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-16
0
0001665988
Bioventus Inc.
BVS
0001904156
McMurry-Heath Michelle
4721 EMPEROR BOULEVARD, SUITE 100
DURHAM
NC
27703
1
0
0
0
Class A common stock
2022-06-16
4
M
0
385
0.00
A
385
D
Restricted Stock Units
2022-06-16
4
M
0
385
0.00
D
Class A Common Stock
385
772
D
Restricted Stock Units
2022-06-17
4
A
0
16648
0.00
A
Class A Common Stock
16648
16648
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
The remaining RSUs shall vest and become exercisable in two approximately equal installments on June 16, 2023 and June 16, 2024, subject to the Non-Employee Director continuing in service on the Issuer's Board of Directors through the applicable vesting date.
The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Non-Employee Director continuing in service on the Issuer's Board of Directors through the applicable vesting date.
/s/ Anthony D'Adamio, Attorney-in-Fact
2022-06-22